- Home
- MLSS
as of 03-06-2026 3:48pm EST
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | LIVINGSTON |
| Market Cap: | 20.8M | IPO Year: | 1996 |
| Target Price: | $1.00 | AVG Volume (30 days): | 146.6K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.22 - $1.11 | Next Earning Date: | N/A |
| Revenue: | $8,629,928 | Revenue Growth: | -12.19% |
| Revenue Growth (this year): | 8.95% | Revenue Growth (next year): | 7.51% |
| P/E Ratio: | -4.71 | Index: | N/A |
| Free Cash Flow: | -2928402.0 | FCF Growth: | N/A |
AI-Powered MLSS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2005 Q1 Q1 2005 Earnings
8-K Apr 5, 2005
Q1 2005 Earnings
8-KApr 5, 2005
8-K 1 d63251_8-k.htm
CURRENT REPORT
8-K
SECURITIES AND
EXCHANGE COMMISSIONWashington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 1, 2005
MILESTONE SCIENTIFIC
INC.(Exact name of Registrant as specified in its charter)
Delaware
001-14053
13-3545623
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
220 South Orange Avenue, Livingston Corporate Park, Livingston, New Jersey 07034(Address of principal executive office) (Zip Code)
Registrant’s telephone number, including area code (973) 535-2717
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act(17 CFR 240.14d-2(b))
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act(17 CFR 240.13e-4(c))
Item 2.02: Results of Operations and Financial Condition.
On April 1, 2005, the registrant issued a press release announcing its financial results for the fiscal year ended December 31, 2004. A copy of the press release is attached as Exhibit 99.1 this report.
Item 9.01: Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits:
Exhibit Number
Description
99.1
Press release, dated April 1, 2005, announcing Milestone’s financial results for the fiscal year ended December 31, 2004.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned, hereunto duly authorized.
MILESTONE SCIENTIFIC INC.
By: /s/ Leonard Osser —————————————— Leonard Osser Chairman and Chief Executive Officer
Dated: April 4, 2005
2
Compare MLSS vs Leading Stocks
See how MLSS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MLSS Milestone Scientific Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.